MX2009007391A - Metodos para aumentar e inmovilizar células madre hematopoyéticas. - Google Patents
Metodos para aumentar e inmovilizar células madre hematopoyéticas.Info
- Publication number
- MX2009007391A MX2009007391A MX2009007391A MX2009007391A MX2009007391A MX 2009007391 A MX2009007391 A MX 2009007391A MX 2009007391 A MX2009007391 A MX 2009007391A MX 2009007391 A MX2009007391 A MX 2009007391A MX 2009007391 A MX2009007391 A MX 2009007391A
- Authority
- MX
- Mexico
- Prior art keywords
- increasing
- stem cells
- hematopoietic stem
- methods
- mobilizing hematopoietic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se proporciona un método para aumentar el número de células madre hematopoyéticas, en la médula ósea, aumentar la movilidad de estas células para migrar de la médula ósea al flujo sanguíneo y a otras partes, y aumentar el número de células madre hematopoyéticas diferenciadas en el flujo sanguíneo.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88416207P | 2007-01-09 | 2007-01-09 | |
US88989307P | 2007-02-14 | 2007-02-14 | |
US93856407P | 2007-05-17 | 2007-05-17 | |
US1324307P | 2007-12-12 | 2007-12-12 | |
PCT/US2008/050644 WO2008086426A2 (en) | 2007-01-09 | 2008-01-09 | Methods for increasing and mobilizing hematopoietic stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009007391A true MX2009007391A (es) | 2009-08-13 |
Family
ID=39609361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009007391A MX2009007391A (es) | 2007-01-09 | 2008-01-09 | Metodos para aumentar e inmovilizar células madre hematopoyéticas. |
Country Status (15)
Country | Link |
---|---|
US (3) | US20100055077A1 (es) |
EP (1) | EP2115124B1 (es) |
JP (1) | JP5389666B2 (es) |
KR (1) | KR101493474B1 (es) |
CN (1) | CN101631850B (es) |
BR (1) | BRPI0806557A2 (es) |
CA (1) | CA2675032A1 (es) |
EA (1) | EA018983B1 (es) |
HK (1) | HK1134835A1 (es) |
IL (1) | IL199766A (es) |
MX (1) | MX2009007391A (es) |
NZ (2) | NZ578928A (es) |
SG (1) | SG177959A1 (es) |
WO (1) | WO2008086426A2 (es) |
ZA (1) | ZA200905378B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101242852B (zh) | 2005-06-13 | 2012-10-10 | 克里夫兰生物实验室公司 | 利用脂肽抵抗细胞凋亡的保护方法 |
EP2502628B1 (en) * | 2006-06-23 | 2016-12-14 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptide sequences involved in cancer |
MX336869B (es) | 2008-11-03 | 2016-02-04 | Alethia Biotherapeutics Inc | Anticuerpos que bloquean espicificamente la actividad biologica de un antigeno de tumor. |
EP2493295A4 (en) * | 2009-10-28 | 2013-05-08 | Ford Henry Health System | METHOD FOR MINIMIZING LESIONS DUE TO RADIATION EXPOSURE |
EP2338521A1 (en) * | 2009-12-28 | 2011-06-29 | Helmholtz-Zentrum für Infektionsforschung GmbH | Lipopeptide- and lipoprotein-conjugates and its use |
WO2012037283A2 (en) * | 2010-09-14 | 2012-03-22 | Mount Sinai School Of Medicine | Admimistration of sns neuroprotective agents to promote hematopoietic regeration |
KR101993259B1 (ko) | 2011-03-31 | 2019-06-27 | 에이디씨 테라퓨틱스 에스에이 | 신장 결합 항원 1에 대한 항체 및 이의 항원 결합 단편 |
DK2802351T3 (da) | 2012-01-09 | 2019-05-13 | Adc Therapeutics Sa | Midler til behandling af triple-negativ brystkræft |
WO2013149064A1 (en) * | 2012-03-30 | 2013-10-03 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells |
WO2013159082A1 (en) | 2012-04-20 | 2013-10-24 | Adhaere Pharmaceuticals, Inc. | Compounds and methods for regulating integrins |
CN104027791B (zh) * | 2013-03-06 | 2016-08-10 | 浙江海正药业股份有限公司 | 药物组合物 |
JP2016518415A (ja) * | 2013-10-21 | 2016-06-23 | アドバンスド ニューロリジェネレイティブ セラピーズ エルエルシー | 加齢と疾患免疫機能障害と細胞老化とをリンパ球系幹細胞で修復する方法、及び治療使用のためのそれらの再適用する方法 |
CN104744563B (zh) * | 2013-12-27 | 2019-02-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 端基具有亲脂性结构的线性脂肽、其制备方法及用途 |
WO2016073733A1 (en) * | 2014-11-06 | 2016-05-12 | Cleveland Biolabs, Inc. | Methods of treating cancer using lipopeptides |
WO2020047236A1 (en) * | 2018-08-30 | 2020-03-05 | The Regents Of The University Of California | Mobilization and collection of peripheral blood hematopoietic stem cells from deceased donors |
CN112851755B (zh) * | 2021-01-13 | 2023-09-01 | 中国人民解放军军事科学院军事医学研究院 | 一种线性脂肽化合物及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US5192553A (en) * | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
DE19822820A1 (de) * | 1998-05-20 | 1999-11-25 | Biotechnolog Forschung Gmbh | Pharmazeutisches Präparat zur Wundbehandlung |
CN101242852B (zh) * | 2005-06-13 | 2012-10-10 | 克里夫兰生物实验室公司 | 利用脂肽抵抗细胞凋亡的保护方法 |
MX2009001445A (es) * | 2006-08-07 | 2009-02-18 | Genzyme Corp | Terapia de combinacion. |
-
2008
- 2008-01-09 JP JP2009545662A patent/JP5389666B2/ja not_active Expired - Fee Related
- 2008-01-09 CA CA002675032A patent/CA2675032A1/en not_active Abandoned
- 2008-01-09 NZ NZ578928A patent/NZ578928A/xx not_active IP Right Cessation
- 2008-01-09 BR BRPI0806557-8A2A patent/BRPI0806557A2/pt active Search and Examination
- 2008-01-09 SG SG2012001392A patent/SG177959A1/en unknown
- 2008-01-09 WO PCT/US2008/050644 patent/WO2008086426A2/en active Search and Examination
- 2008-01-09 KR KR20097016496A patent/KR101493474B1/ko not_active IP Right Cessation
- 2008-01-09 MX MX2009007391A patent/MX2009007391A/es active IP Right Grant
- 2008-01-09 CN CN2008800077612A patent/CN101631850B/zh not_active Expired - Fee Related
- 2008-01-09 EA EA200900806A patent/EA018983B1/ru not_active IP Right Cessation
- 2008-01-09 EP EP08705809.5A patent/EP2115124B1/en not_active Not-in-force
- 2008-01-09 NZ NZ603805A patent/NZ603805A/en not_active IP Right Cessation
- 2008-01-09 US US12/522,606 patent/US20100055077A1/en not_active Abandoned
-
2009
- 2009-07-08 IL IL199766A patent/IL199766A/en not_active IP Right Cessation
- 2009-07-31 ZA ZA200905378A patent/ZA200905378B/xx unknown
-
2010
- 2010-03-23 HK HK10103026.0A patent/HK1134835A1/xx not_active IP Right Cessation
-
2013
- 2013-07-02 US US13/933,954 patent/US20140045747A1/en not_active Abandoned
-
2015
- 2015-03-04 US US14/638,888 patent/US20150174195A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20140045747A1 (en) | 2014-02-13 |
EP2115124A4 (en) | 2012-05-30 |
NZ603805A (en) | 2014-03-28 |
NZ578928A (en) | 2013-03-28 |
CN101631850B (zh) | 2013-12-04 |
WO2008086426A8 (en) | 2009-07-30 |
AU2008204836A1 (en) | 2008-07-17 |
JP5389666B2 (ja) | 2014-01-15 |
KR101493474B1 (ko) | 2015-02-16 |
US20150174195A1 (en) | 2015-06-25 |
WO2008086426A3 (en) | 2008-12-18 |
EP2115124A2 (en) | 2009-11-11 |
EA018983B1 (ru) | 2013-12-30 |
SG177959A1 (en) | 2012-02-28 |
WO2008086426A2 (en) | 2008-07-17 |
HK1134835A1 (en) | 2010-05-14 |
CA2675032A1 (en) | 2008-07-17 |
ZA200905378B (en) | 2010-05-26 |
CN101631850A (zh) | 2010-01-20 |
EA200900806A1 (ru) | 2010-08-30 |
JP2010515748A (ja) | 2010-05-13 |
BRPI0806557A2 (pt) | 2014-04-15 |
KR20090108703A (ko) | 2009-10-16 |
EP2115124B1 (en) | 2016-03-16 |
IL199766A (en) | 2015-01-29 |
US20100055077A1 (en) | 2010-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009007391A (es) | Metodos para aumentar e inmovilizar células madre hematopoyéticas. | |
HK1247954A1 (zh) | 由人類多能幹細胞產生間充質幹細胞的方法以及通過所述方法產生的間充質幹細胞 | |
IL189882A0 (en) | Method of deriving mesenchymal stem cells | |
EP2438161B1 (en) | PROCESS FOR THE PRODUCTION OF PLURIPOTENT STEM CELLS AND THEIR CULTURE PROCESS | |
EP2374871A4 (en) | PLURIPOTENT STEM CELLS, PROCESS FOR PREPARING THE SAME, AND USES THEREOF | |
EP2545928A4 (en) | PREPARATION OF CELLS CONTAINING MESENCHYMAL STEM CELLS AND PROCESS FOR PRODUCTION THEREOF | |
MY159971A (en) | Multipotent/pluripotent cells and methods | |
EP2639293A4 (en) | CELL CULTURE CHAMBER, METHOD FOR PRODUCING THE SAME, FABRIC MODEL USING THE CELL CULTURE CHAMBER AND METHOD FOR PRODUCING THE SAME | |
EP2231992A4 (en) | METHOD AND DEVICE FOR IMPROVING THE DESIGN, PRODUCTION, PERFORMANCE AND / OR USE OF DRILLING TOOLS | |
WO2010124142A3 (en) | Cell compositions derived from dedifferentiated reprogrammed cells | |
MX2013014307A (es) | Metodo de tratamiento de celulas madre mesenquinales y su uso en el tratamiento de enfermedades asociadas a estres oxidativo. | |
WO2010059565A3 (en) | Allografts combined with tissue derived stem cells for bone healing | |
IL216902A0 (en) | Methods for culturing stem and progentitor cells | |
EP1974022A4 (en) | MASS PRODUCTION PROCESS FOR GROWTH FACTOR USING FAT-WEB-GENERATING ADULTS STEM CELLS | |
ZA201202685B (en) | Methods of preparing mesenchymal stem cells,compositions and kit thereof | |
SG10201402428WA (en) | Method of efficiently establishing induced pluripotent stem cells | |
EP2594636A4 (en) | CULTURE MEDIUM COMPOSITION FOR CULTURING MESENCHYMAL STEM CELLS FROM AMNIOTIC MEMBRANE, AND METHOD FOR CULTURING THE SAME USING THE SAME | |
PL2495302T3 (pl) | Urządzenie biologiczne do ekstrakcji krwiotwórczych komórek macierzystych i mezenchymalnych komórek macierzystych z krwi obwodowej | |
WO2010129441A3 (en) | Method for separating stem cells from their more differentiated progeny using microfluidic devices | |
EP2119768A4 (en) | METHOD FOR MANUFACTURING MESENCHYMAL CELL, METHOD FOR MANUFACTURING TOOTH AND MESENCHYMAL CELL FOR TOOTH FORMATION | |
WO2007041546A3 (en) | Method for selectively depleting hypoxic cells | |
ZA200904706B (en) | Process to produce biomass and proteins by microalgae | |
EP2596097A4 (en) | MESENCHYMAL BONE MARROW STEM CELLS WITH HIGH TELOMERASE ACTIVITY, METHOD FOR THE PRODUCTION THEREOF, AND PHARMACEUTICALS AND TREATMENT METHODS ON THEIR BASIS | |
PL2621505T3 (pl) | Sposób wytwarzania niezawierających alkoholu kompozycji na bazie roślin i wytworzone w ten sposób kompozycje oraz ich zastosowanie | |
WO2011143400A3 (en) | Method and composition for inducing human pluripotent stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |